血清代谢物与慢性肾脏病全因死亡相关
研究在MDRD队列299例CKD患者中通过非靶向代谢组学发现6种代谢物与死亡相关,并在AASK队列963例CKD患者中验证,其中富马酸、尿囊素和核糖酸三种代谢物可重复关联全因死亡,且独立于肾功能指标。
要点
- 富马酸、尿囊素和核糖酸与CKD患者长期全因死亡独立相关。
- 关联在调整人口学、临床协变量、尿蛋白和实测GFR后仍显著。
- 两种代谢物每倍增的校正风险比在两项队列中一致且meta分析相似。
核心结论
- 在MDRD和AASK两个CKD队列中,富马酸、尿囊素和核糖酸与长期全因死亡可重复关联,且独立于肾功能指标。
研究设计与样本
- 发现队列为MDRD研究中299例CKD患者,采用非靶向液相色谱-质谱联用定量血清代谢物。
主要发现
- MDRD队列中位随访17年,622种代谢物中6种与死亡显著相关。
- AASK队列中富马酸、尿囊素和核糖酸三种代谢物重复验证了与死亡的关联。
- Meta分析中每倍增代谢物的校正风险比分别为1.63、1.59和1.61。
关键数值与推荐
- 富马酸、尿囊素和核糖酸每倍增的校正风险比分别为1.63、1.59和1.61。
临床怎么用
- 这些代谢物可作为CKD患者死亡风险研究的候选靶点,尚不能直接用于临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) involves significant metabolic abnormalities and has a high mortality rate. Because the levels of serum metabolites in patients with CKD might provide insight into subclinical disease states and risk for future mortality, we determined which serum metabolites reproducibly associate with mortality in CKD using a discovery and replication design. Metabolite levels were quantified via untargeted liquid chromatography and mass spectroscopy from serum samples of 299 patients with CKD in the Modification of Diet in Renal Disease (MDRD) study as a discovery cohort. Six among 622 metabolites were significantly associated with mortality over a median follow-up of 17 years after adjustment for demographic and clinical covariates, including urine protein and measured glomerular filtration rate. We then replicated associations with mortality in 963 patients with CKD from the African American Study of Kidney Disease and Hypertension (AASK) cohort over a median follow-up of ten years. Three of the six metabolites identified in the MDRD cohort replicated in the AASK cohort: fumarate, allantoin, and ribonate, belonging to energy, nucleotide, and carbohydrate pathways, respectively. Point estimates were similar in both studies and in meta-analysis (adjusted hazard ratios 1.63, 1.59, and 1.61, respectively, per doubling of the metabolite). Thus, selected serum metabolites were reproducibly associated with long-term mortality in CKD beyond markers of kidney function in two well characterized cohorts, providing targets for investigation.
引用
- Hu JR, Coresh J, Inker LA, et al. Serum metabolites are associated with all-cause mortality in chronic kidney disease. Kidney Int. 2018. PMID: 29871777. doi:10.1016/j.kint.2018.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。